, Middlesex. UK. 3-Hydrory-3-methylglutaric (HMO) aciduria is a disorder of L-leucine metabolism and ketone body biosynthesis characteriaed by recurrent acute life-threatening episodes resembling Reye's syndrome. Prenatal diagnosis was requested by the parents of a child with this condition and was carried out by amniocenteeis at 16 weeks' gestation. Amniotic fluid concentrations (capillary GC and GC-HS) (Umole/L) were for W G 34.6 (N=1.21+0.38), 3-hydroryisovalerate (HIV) 33.9 (N=4.78f1.91). 3-methylglutaconate (3MAG) 31.7 (N=0.62-0.90) and 3-methylglutarate(3MG) 1.23 (N=0.12-0.26) consistent with an affected fetus. Termination was carried out on the basis of these data. The diagnosis was confirmed immediately by analysis of fetal plasma for organic acid6:concentrations of HMG, HIV, 3MAG and 3MG were 67.3, 36.9, 31.3 and 11.31lmoles/L respectively. Subsequent enzymology on cultured amoiocytes gave mean results for isovalerate incorporation into protein (pmol/h/mg protein) of 48 compared to simultaneous controls of 252; direct WIG CoA lyaS-3 activity (moles ilMG CoA removed/min/mg protein) was 0.05 compared to simultaneous controls of 9.16. Direct HMG CoA lyase measurements on chorionic villus tissue obtained at termination gave mean activities of 0.87 compared to controls of 8.04. These results provide the first prenatal diagnosis of HMG aciduria, demonstrate the rapid, accurate and unambiguous diagnosis at 16 weeks using direct GC-MS analysis of amniotic fluid and indicate the suitability of chorionic villus biopsy for future earlier (9 weeks) prenatal diagnoses of this condition.
Intrigued by the persistent growth retardation of some glucose-6-phosphatase-deficient patients, we investigated the urinary excretion of lactate, 2-oxoglutarate and citrate, reflecting organic acid overproduction, and glycerol reflecting impaired gluconeogenesis, in 17 patients with type I A and 1 patient with type IB glycogenosis. The urine was collected during 8-10 successive days twice daily.
The mean lactate-creatinine ratio (mM/mM) ranged from 0.27 to 11.17 (normal 0.010 to0.058, N=36) in 5 patients with a height < P3. The lactate excretion in these patients varied considerably during successive days and less during gastric drip feeding at night. The mean lactate-creatinine ratio in the other patients was more constant and ranged from 0.04 to 0.34, The mean 2-oxoglutarate-creatinine ratio (mM/mM) ranged from 0.17 to 0.84 (normal 0 to 0.05, N=15) in 4 of 5 growth retarded patients. In the other patients it ranged from 0.01 to 0.43. The 2-oxoglutarate excretion per patient varied little. The mean citrate-creatinine ratio (mM/mM) ranged from 0.03 to 0.84 in all patients (normal 0.12 to 0.73, N=15). The mean glycerol-creatinine ratio (mM/mM) ranged from 0.01 to 0.11 (normal 0.005 to 0.03, n=15).
We conclude that the lactate-creatinine ratio reflects both the adequacy of the dietary treatment and the severity of the disease, whereas the 2-oxoglutarate-creatinine ratio reflects mainly the latter. The citrate-creatinine ratio and the glycerol-creatinine ratio do not give important information. Two forms for the UDP-galactose-epimerase (EP) deficiency have been reported, one benign and the other severe. Through the routine screening of galactosemia recently we found three patients who had a deficient EP activity in erythrocytes. The EP activity assayed with a twostep radioisotopic method (Clin. Chem. 28, 2322 , 1982 was 9.3, 11.5 and 7.9 umol/h/g Hb respectively (normal range 18-35, n-55). The former patients who showed no apparent clinical symptoms had a mild elevation in galactose-l-phosphate (GP) in erythrocytes (21 and 1 8 pmol/L) and a normal galactitol (GL) in plasma. GP was determined enzymatically (Clin. Chim. Acta 127, 77, 1902) with the normal range of 1-12, and GL by gas chromatography-mass spectrometry (Pediatr. Res. 18, 714, 1984) with the normal range of 0.00-0.91 pmol/L. However, after a short treatment with galactose-free diets GP was normalized in these patients. The third patient whosc clinical pictures were similar to those of classical galacosemia with congenital cataracts revealed an extremely high level of GP (310.0) and GL (99.1). The EP acivity in the liver biopsy of the first patient was completely normal suggesting that the former patients have a partial deficiency possibly due to the E P isoenzymes.
METABOLITE PATTERNS AND CLINICAL EXPRESSIONS OF

FAMILIAL SUDDEN CHILD DEATH IN A FAMILY WITH PSEUDO-DOMI-
16
NANT DIFARBOXYLIC ASIDURIA AND HYP9KLTOTIC HYZCGLYCEMIA.
M Duran , M Hofkamp , JM Saudubray , WJ Rhead , SK wadman' I. Univ. Children's Hosp.'Het Wilhelmina Kinderziekenhuis'. Utrecht. Netherlands, 2.Lukas Hosp., Apeldoorn, Netherlands, 3. H8p. Necker Enfants Malades, Paris, France, 4.Dept. Pediatr. Univ. Iowa City, USA.
A family is described in which the father and three (and probably all four) children had a decreased capacity for the oxidation of nediunn chain fatty acids resulting in a defective ketogenesis. The 4th child died at the age of 16 months during an episode of hypoketotic hypoglycemia (plasma glucose 0.7 mmole/l; 3-hydroxybutyrate 1.7 mmoles/l).Previously the child had always been in good health. Medium-chain fatty ecids accumulated in the patient's plasma; the urinary organic acid profile showed large amounts of dicarboxylic acids and fatty acid conjugates such as hexanoylglycine, octanoylcarnitine, and octanoylglucuronide. The activity of medium-chain acyl-CoA dehydrogenase in an autopsy liver sample was only 15% of the mean control. The first child had died at the age of 19 months under similar conditions. W e n subjeb ted to a 17 h fast the father and the 2nd and 3rd child, but =the wther, accumulated octanoic, decanoic and cis-4-decenoic acids in their plasma.Their urinary organic acid profile resembled that of the deceazed 4th child, but excretions were at a lower level. Measurement ~f [ -c]-octanoate degradation in cultured fibroblasts revealed low values for the father and the two 'healthy' children as compared to the controls. It is suggested that a -partial-deficiency of medium-chain scyl-CoA dehydrogenase may lead to life-threatening illness when gastro-intestinal abnormalities eventually lead to a severe depletion of +he glycogen stores. Careful monitoring of at-risk patients is indicated under these circumstances.
ARGININE-GLYCINE TRANSAMIDINAGE IN BOVINE NEURORETlNB
Hospital, University of Helsinki, Helsinki, Finland Gyrate atrophy (611 patients exhibit chor~oretinal degeneration and histologic muscle abnormalities. Due to autosonal recessive deficiency of ornithine aminotransferase they accumulate ornithine to levels, which are lox normal and well above the K, of arqinine-glycine translaidinane of rat kidney. He have previously shown inadequate synthesis of guanidinoacetate and low creatine concentration in plasma, urine, erythrocytes, and muscle tissue of 61 patients.
Supplementary creatine corrected the atrophic muscle pathology but the chorioretinal atrophy continued. We alleged that this discrepancy was due to ineffective transport of creatine across the blood-eye barrier and sought for synthesis of quanidinorcetate in ocular trssues.
Ue developed a new assay for measuring the arqinine-qlycine transamidinase activity in bovine eye tissues with a new assay based on the detection of formed guanidinoacetate wlth alkaline ninhydrin reaction.
Ye found transamidinase activity only in the fisuroretina INFO and retinal pigment epithelium (RPEI. The pH optimua was 7.5 in NR and 7.9 In RPE and the apparent K. for arginine was 1.10 In NR and 4.96 nli In RPE, and for glycine 1.03 and 0.95 an,
respectively.
Our results indicate that a potential energy-rich phosphagen compound can be forned in eye tissues. Reduction of the ornithine concentration in ocular tissues can possibly enable the transanidination also in gyrate atrophy. In patients B and C (brother and sister) follow-up showed a slowing of weight gain and, to a lesser degree, of length growth. In patient 8 , weight and length at the age of 3 9/12 y were at the 3rd percentile but at the age of 5 3/12 y they were 2 kg and 7 cm respectively below the 3rd percentile. In patient C, weight and length at the age of 1 6/12 y were at the 25th and at the 75th percentiles respectively. while at the age of 3 6/12 y weight was 1.5 kg below the 3rd percentile and length at the 25th percentile. Serum muscle enzymes, electromyography, nerve conduction velocity and muscle histology were normal in both patients. Patient A, in contrast, had a normal weight gain and growth. Adenylosuccinase activity (nmol/min mg protein vs means + SEM in 8 controls) was deficient in skeletal muscle of patients B and C (0.18 and 0.66 vs 2.61 + 0.34) but normal in patient A.
No abnormalities of muscle nucleotide profiles could be detected. Conclusion : these findings indicate clinical and biochemical heterogeneity in adenylosuccinase deficiency. The presence of this deficiency in skeletal muscle of patients B and C only, suggests a causal relationship between this defect and their muscular wasting.
